Related content

Gene Therapy for Pyruvate Dehydrogenase E1 Deficiency Using Recombinant Adeno-Associated Virus 2 (rAAV2) Vectors

By Owen R.   Mandel R.J.   Ammini C.V.   Conlon T.J.   Kerr D.S.   Stacpoole P.W.   Flotte T.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 394-399

Elsevier

Access to resources Recommend Favorite

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

By Fu H.   Muenzer J.   Samulski R.J.   Breese G.   Sifford J.   Zeng X.   McCarty D.M.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 911-917

Elsevier

Access to resources Recommend Favorite

Intramuscular Administration of Recombinant Adeno-Associated Virus 2 -1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic Aspects

By Song S.   Scott-Jorgensen M.   Wang J.   Poirier A.   Crawford J.   Campbell-Thompson M.   Flotte T.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 329-335

Elsevier

Access to resources Recommend Favorite

Eradication of Simian Retrovirus Type D From a Colony of Cynomolgus, Rhesus, and Stump-tailed Macaques By Using Serial Testing and Removal

By Schroder Monica A.   Fisk Stephen K.   Lerche Nicholas W.  

Journal of the American Association for Laboratory Animal Science, Vol. 39, Iss. 4, 2000-07 ,pp. : 16-23

American Association for Laboratory Animal Science

Access to resources Recommend Favorite

Novel semliki forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression

By Lundstrom K.   Abenavoli A.   Malgaroli A.   Ehrengruber M.U.  

Molecular Therapy, Vol. 7, Iss. 2, 2003-02 ,pp. : 202-209

Elsevier

Access to resources Recommend Favorite